WuXi PharmaTech Provides Update of 2010 Financial -

69c15rqn26jh · Szeregowy paszczak

WuXi PharmaTech (NYSE: WX), a leading pharmaceutical,[link widoczny dla zalogowanych], biotechnology,[link widoczny dla zalogowanych], and medical-device research and development outsourcing company, with operations in China and the United States,[link widoczny dla zalogowanych], today announced that it will present at the 29th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2011 at 3:30 p.m. Pacific Standard Time and updated its 2010 financial guidance. Based on preliminary,[link widoczny dla zalogowanych], unaudited results,[link widoczny dla zalogowanych], WuXi expects to slightly exceed the top end of its previous guidance for 2010 total net revenues of $330-333 million and to exceed year-over-year growth in 2010 non-GAAP operating income of 28-32%. The company also expects to achieve the remainder of the 2010 financial guidance found in its third-quarter 2010 earnings release.
The company plans to report its audited fourth-quarter and full-year 2010 financial results and to provide 2011 financial guidance in March 2011.